Welcome to LMC Healthcare, our new company name with a fresh, new look! We’re Here for You Canada’s largest and most trusted specialist care provider in diabetes & endocrinology Dedicated to transforming diabetes care for the better by making it...
On October 6-8th, 2017, LMC?Manna Research’s Management Team was represented at the Society of Clinical Research Sites (SCRS) annual Global Solutions Summit Conference in Boca Raton, Florida. Nazneen Qureshi, Manager Patient Engagement, representing LMC | Manna...
LMC | Manna Research’s own Lydia Frost, Regional Site Lead – Research, won the 2017 Clinical Research Coordinator of the Year – The Americas Award, presented by PharmaTimes Media Ltd. This year’s competition was held in association with the ACRP 2017...
LMC’s telemedicine service is dedicated to the provision of medical consultation and follow-up services for Diabetes & Endocrine conditions to individuals over the age of 18 living in the various LHIN’s. We have recently begun accepting referrals from...
Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. “The...
